Prerenal azotemia is a condition characterized by an increase in the level of nitrogen in the blood due to insufficient blood supply to the kidneys, which leads to impairment of their function. This disorder can occur as a consequence of various systemic diseases, hypovolemic states, shock, and significant fluid loss or fluid associated with a decrease in blood volume. Tissue hypoxia and poor perfusion lead to impaired glomerular filtration, which causes the accumulation of nitrogen-containing substances, such as urea and creatinine, in the blood serum. It is important to note that prerenal azotemia can be reversible with timely elimination of the causes that caused the hemodynamic impairment.
History of the disease and interesting historical facts
Prerenal azotemia is a clinical entity known for many decades. The first mentions of renal diseases associated with insufficient perfusion can be found in the works of ancient Greek physicians. Avicenna in his famous work "The Canon of Medicine" described a condition similar to prerenal azotemia, associating it with a violation of the fluid balance in the body. Modern studies of this condition began to actively develop in the 20th century, when laboratory diagnostic methods for kidney function and blood analysis appeared. Understanding the mechanisms underlying prerenal azotemia became possible due to the development of physiology and nephrology.
Epidemiology
The prevalence of prerenal azotemia varies by population and setting. In general practice, this syndrome is often encountered in patients with acute conditions such as shock, hypovolemia, or surgery. In one study of hospital patients, prerenal azotemia was found to occur in 40-70% of patients with acute renal failure. According to various studies, prerenal azotemia accounts for 30-50% of all cases of acute kidney injury.
Genetic predisposition to this disease
Prerenal azotemia is most often caused by acute, acquired conditions, but certain genetic factors may predispose the kidneys to decreased bioavailability and wasting. Studies have shown that vascular system disorders, such as the hereditary angiotensin gene, as well as genes responsible for blood regulation in the kidneys, may have a significant impact. For example, polymorphisms of genes associated with the renin-angiotensin system may increase the risk of hypertension and renal oxygen starvation, which increases the likelihood of developing prerenal azotemia.
Risk factors for the development of this disease
Risk factors for prerenal azotemia are varied and include both physical and chemical aspects:
- Hypovolemia caused by severe bleeding, dehydration, or fluid loss.
- Infectious diseases leading to shock or sepsis.
- The presence of cardiovascular diseases such as heart failure.
- Taking certain medications, such as diuretics, which can cause dehydration.
- Operations involving prolonged general anesthesia.
- Liver diseases and cirrhosis leading to hemodynamic impairment.
Diagnosis of this disease
The diagnosis of prerenal azotemia is based on a combination of clinical signs and laboratory tests. The main symptoms that indicate possible prerenal azotemia include:
- Tachycardia and hypotension, indicating a decrease in circulating blood volume.
- Symptoms of shock such as weakness and sweating.
- Change in urine color, possible decrease in urine volume.
Laboratory tests include:
- Measurement of serum creatinine and urea levels.
- Urine analysis to determine osmolarity and creatinine output ratio.
- Serum electrolytes (sodium and potassium).
Radiological studies are performed to rule out other causes of kidney dysfunction. Ultrasound is commonly used to evaluate the size and structure of the kidneys.
Treatment
Treatment of prerenal azotemia should be directed at eliminating the causes of the perfusion deficit. General approaches to treatment include:
- Correction of hypovolemia by infusion therapy.
- Use of drugs that increase blood pressure, such as norepinephrine, in septic shock.
- Monitoring electrolyte balance and correction of disorders.
Pharmacological treatment may include:
- Diuretics when necessary to reduce swelling in heart disease.
- Cardiovascular drugs to improve perfusion.
Surgical treatment may be required for hemodynamically significant conditions such as thrombosis, as well as for operations on organs that affect the blood supply to the kidneys.
List of medications used to treat this disease
Among the drugs used to correct prerenal azotemia, the following can be distinguished:
- Crystalloids (saline, Ringer's).
- Colloids.
- Norepinephrine for the treatment of hypotension.
- Diuretics (furosemide) for edema.
- Electrolyte balance correctors (potassium, sodium).
Disease monitoring
Monitoring of prerenal azotemia includes regular checks of creatinine and urea levels, as well as monitoring of blood pressure and heart rate. The prognosis is favorable in most cases if prompt medical attention is sought and the cause of the condition is eliminated. However, complications such as progression of acute kidney injury and transition to chronic renal failure may occur.
Age-related features of the disease
Prerenal azotemia may present differently in different age groups. In the elderly, this condition is more common in the presence of comorbidities, which increases the risk of renal dysfunction. In children, traumatic causes and dehydration are most often immediate triggers, while in the young and adults, special attention should be paid to infections and shock.
Questions and Answers
- What are the main symptoms of prerenal azotemia? The main symptoms include weakness, hypotension, tachycardia and decreased urine output.
- What are the main causes of prerenal azotemia? Causes range from hypovolemia, cardiovascular disease, to infections causing shock.
- How is prerenal azotemia diagnosed? Diagnosis is based on clinical manifestations, laboratory tests and ultrasound examination of the kidneys.
- What is the treatment for prerenal azotemia? Treatment is based on correcting the volume of fluid and eliminating the cause, for example, crystalloids are used for resuscitation.
- What is the prognosis for prerenal azotemia? The prognosis is usually favorable with adequate and timely therapy, but complications may occur.
